Virtual Medicinal Product (VMP) - Alteplase 50mg powder and solvent for solution for infusion vials

Navigation

Name Details

Name Start Date End Date
Name Current Name Alteplase 50mg powder and solvent for solution for infusion vials Start Date 11-05-2009 End Date
Previous Name Previous Name Alteplase 50mg powder and solvent for solution for injection vials Start Date 10-06-2004 End Date 10-05-2009
Abbreviated Name Abbreviated Name Alteplase 50mg inf vials Start Date 11-05-2009
Previous Abbreviated Name Alteplase 50mg inj vials Previous Start Date 01-05-2009 Previous End Date 10-05-2009

Unit Dose & Form Information

DF Indicator
Discrete
UDFS Indicator
1
UDFS UOM
vial
Unit Dose UOM
vial

Summary

Prescribing Status
Valid as a prescribable product
Controlled Drug Category
No Controlled Drug Status
Route
Intravenous
Form
Powder and solvent for solution for infusion
Ontology Form/Route
solutioninfusion.intravenous, solutioninjection.intravenous
Name Basis
rINN - Recommended International Non-proprietary

Codes

ATC Code
B01AD02
BNF Start Date End Date
Current BNF 02100200 Start Date 04-04-2022 End Date
Previous BNF 02100200 Start Date 11-02-2005 End Date 03-04-2022
SNOMED Codes
Code Start Date End Date
35899411000001101 17-10-2018
319837006 04-09-2003 16-10-2018

VMP Ingredients

VMP ingredients table
Name Basis of Strength Description BOSS Strength and UOM (Nmr) Strength and UOM (Dmr)
Alteplase Based on Ingredient Substance 50 mg

Parent Products

Virtual Medicinal Product Pack (VMPP) Information

Pack Size Drug Tariff Price Drug Tariff Payment Category
1 vial